These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 14727425)

  • 1. [Distortion product otoacoustic emission test of cochlear deafness].
    Liu A; Cui Y; Ge X; Wang C
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Oct; 17(10):588-90. PubMed ID: 14727425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A validation and potential clinical application of multivariate analyses of distortion-product otoacoustic emission data.
    Gorga MP; Dierking DM; Johnson TA; Beauchaine KL; Garner CA; Neely ST
    Ear Hear; 2005 Dec; 26(6):593-607. PubMed ID: 16377995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on distortion product otoacoustic emissions and expanded high frequency audiometry in noise exposure workers].
    Han J; Li F; Zhao C; Zhang Z; Ni D
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2003 Jan; 17(1):16-9. PubMed ID: 12725180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing Clinical Interpretation of Distortion Product Otoacoustic Emissions in Infants.
    Blankenship CM; Hunter LL; Keefe DH; Feeney MP; Brown DK; McCune A; Fitzpatrick DF; Lin L
    Ear Hear; 2018; 39(6):1075-1090. PubMed ID: 29517520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of distortion product otoacoustic emissions in detection of pseudohypacusis and exaggerated hearing loss].
    Li F; Liang R; Chen C; Song W
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Apr; 20(7):303-5. PubMed ID: 16780143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Studies of the evaluation of cochlea function with distortion product otoacoustic emission].
    Kashiwamura M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):641-62. PubMed ID: 10036620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distortion product otoacoustic emission response characteristics in older adults.
    Torre P; Cruickshanks KJ; Nondahl DM; Wiley TL
    Ear Hear; 2003 Feb; 24(1):20-9. PubMed ID: 12598810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Applying distortion product otoacoustic emission in testing human sensory hearing loss].
    Chen X; Zheng H; Zheng Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2004 May; 35(3):382-4. PubMed ID: 15181843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results for audiology and distortion product and transient evoked otoacoustic emissions in patients with systemic lupus erythematosus.
    Karabulut H; Dagli M; Ates A; Karaaslan Y
    J Laryngol Otol; 2010 Feb; 124(2):137-40. PubMed ID: 19852869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnosis of sensorineural hearing loss with neural networks versus logistic regression modeling of distortion product otoacoustic emissions.
    Ziavra N; Kastanioudakis I; Trikalinos TA; Skevas A; Ioannidis JP
    Audiol Neurootol; 2004; 9(2):81-7. PubMed ID: 14981356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A review of the effectiveness of otoacoustic emissions for evaluating hearing status after newborn screening.
    Janssen T
    Otol Neurotol; 2013 Aug; 34(6):1058-63. PubMed ID: 23628790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of cochlear function with distortion products of otoacoustic emissions in acoustic neuroma].
    Oeken J
    HNO; 1996 Dec; 44(12):677-84. PubMed ID: 9081952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of the correspondence between pure tone and distorsion product otoacoustic emissions audiometrics: basis for an objective cochlear audiometrics model].
    Jürgens A; Buisan A; Canela M; Abelló P
    Acta Otorrinolaringol Esp; 1999 May; 50(4):253-9. PubMed ID: 10431072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of cochlear hearing disorders: normative distortion product otoacoustic emission measurements.
    Mills DM; Feeney MP; Gates GA
    Ear Hear; 2007 Dec; 28(6):778-92. PubMed ID: 17982366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tone-burst and click-evoked otoacoustic emissions in subjects with hearing loss above 0.25, 0.5, and 1 kHz.
    Jedrzejczak WW; Kochanek K; Trzaskowski B; Pilka E; Skarzynski PH; Skarzynski H
    Ear Hear; 2012; 33(6):757-67. PubMed ID: 22710662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
    Dille MF; McMillan GP; Reavis KM; Jacobs P; Fausti SA; Konrad-Martin D
    J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.